Highlights
NASDAQ: CARA       Cara Therapeutics
Last Price Today's Change   Day's Range   Trading Volume
16.57   +0.17 (1.04%)  16.49 - 17.61  1,033,100

Overview

 
Avg Volume (4 weeks):1,086,794
4 Weeks Range:15.86 - 26.67
4 Weeks Price Volatility (%):
6.57%
52 Weeks Range:12.19 - 27.55
52 Weeks Price Volatility (%):
28.52%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Cara Therapeutics is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara’s objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

  Be the first to like this.
 


 

3995  4101  641  182 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 EEM 44.42-0.02 
 SPY 317.32+0.19 
 AMD 41.15-1.44 
 VXX 15.53-0.67 
 DHR 148.52-2.78 
 CHK 0.789+0.006 
 FXI 42.60-0.18 
 GE 11.34-0.10 
 BAC 34.44-0.24 
Partners & Brokers